The drug development industry has come along way in the last two decades. In the 1980s and early 1990s, when the focus was on cost-savings and capacity management, contract research organizations (CROs) were used primarily as spillover capacity. The work was done and often done well, but our relationship with our pharmaceutical clients was tactical, and CRO growth rates and profitability were volatile. From roughly 2000 to 2005, biotechnology and specialty pharmaceutical companies began to use CROs more strategically, which stabilized demand and improved the performance and return on investment of CROs.

Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $1.8 billion, employees in more than 60 countries, and more than 10,000 employees worldwide The drug development industry has come along way in the last two decades. In the 1980s and early 1990s, when the focus was on cost-savings and capacity management, contract research organizations (CROs) were used primarily as spillover capacity. The work was done and often done well, but our relationship with our pharmaceutical clients was tactical, and CRO growth rates and profitability were volatile. From roughly 2000 to 2005, biotechnology and specialty pharmaceutical companies began to use CROs more strategically, which stabilized demand and improved the performance and return on investment of CROs.

CytoSorbents Inc. is located in Monmouth Junction, New Jersey. CytoSorbents Inc., formerly known as MedaSorb Technologies, Inc., is the operating company of MedaSorb Technologies Corporation (www.medasorb.com). CytoSorbents Inc. is a medical device company that has developed a new adsorbent platform technology for removal of toxins from blood and physiologic fluids. CytoSorbent's products are comprised of porous, adsorbent polymer beads that target molecules up to 50,000 Daltons, such as pro-inflammatory and anti- inflammatory cytokines i.e. IL-1, IL-6, TNF and Il-10, which are associated with sepsis. These cytokines are believed to be largely untouched by current blood purification techniques, including state of the art dialysis technology. Our near term focus is achieving regulatory approval of CytoSorb™ which is expected to be used for the treatment of sepsis, cardiopulmonary bypass surgery, organ donation and drug overdoses, all of which have a common theme, blood borne toxins.

diaDexus is a diagnostics company, located in South San Francisco, California, focusing on the development and commercialization of patent-protected in vitro diagnostic products addressing unmet needs in cardiovascular disease. diaDexus was formed in 1997 as a joint venture between SmithKline Beecham (now GlaxoSmithKline) and Incyte; upon formation, GSK granted diaDexus an exclusive license to certain diagnostic intellectual property, including the PLAC Test for Lp-PLA2. The PLAC Test is the only blood test cleared by the FDA to assess risk for coronary heart disease and ischemic stroke associated with atherosclerosis.

Diagnostic Laboratory Services (DLS) provides clinical laboratory and employee drug screening services in Hawaii and other Pacific islands. The company's toxicology department provides drug testing services for private companies, federal and state agencies, and health care providers. DLS' microbiology department provides infectious disease testing services. The company also provides provides diagnostic pathology lab services, including biopsy and pap smear analysis, through affiliate Hawaii Pathology Laboratory. DLS operates satellite locations throughout the Hawaiian Islands, Guam, and Saipan and has hospital-based laboratories including one at the affiliated Queen's Medical Center in Honolulu.

Enzo Biochem is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. Founded in 1976, we have concentrated on the development of enabling technologies in the areas of gene regulation and gene modification. Many of our technologies are applicable to the biomedical and pharmaceutical research markets, and we are further using these technologies as a platform for our entry into the clinical diagnostics market.

ERT is passionate and committed about transforming the way you conduct your drug development and healthcare efforts. Understanding that you need the most accurate, cost-effective and convenient support systems to collect timely, regulatory-compliant data, our team of experts will work together with you to ensure joint success. You expect unparalleled service, proven process and leading technology managed by professionals you can trust – ERT strives to continually achieve and improve in all areas, ensuring our pledge to you of getting it done right.

eScreen, Inc. develops, manufactures and markets employment screening products for hiring and maintaining an efficient workforce. eScreen currently deploys proprietary technology to Occupational Health Clinics nationwide. This technology creates an electronic, web-based preferred network for businesses seeking faster drug test results and paperless transactions. eScreen currently processes millions of healthcare and corporate data transactions a year through the eScreen Occupational Health Network (EOHN).

Esoterix is a specialized laboratory service provider focused on high science, superior customer service, and innovative new products. Through an extensive client base that includes hospitals, physician specialists and bio-pharmaceutical companies, Esoterix provides a level of expertise and scientific excellence unsurpassed in the industry. Esoterix is a wholly owned subsidiary of Laboratory Corporation of America where it's laboratories operate as Centers of Excellence for specialized services and esoteric testing.

GeneLink Biosciences, Inc. is a genomics biotechnology company engaged in genetic profile development, product development, business development and support services for its subsidiaries and distribution partners. GeneLink's patented and patent pending technologies include proprietary genetic assessments and products linked to personalized health, beauty and wellness applications. Its DNA assessments provide information that enables the customization of nutritional products, skincare products and health maintenance regimens genetically matched to an individual customer's needs.

Inviting Real Estate Agents, Job Placements Agents, Educational Institutes, Software Service Providers, Real Estate Builders, Marriage Bureaus, Travel Agents, Restaurant Owners, Health & Fitness Centers and other Local Businesses to Post a FREE Classified Advertisement on Cootera.com Classifieds Website.